198 related articles for article (PubMed ID: 8667077)
1. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
[TBL] [Abstract][Full Text] [Related]
2. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.
Kasina S; Rao TN; Srinivasan A; Sanderson JA; Fitzner JN; Reno JM; Beaumier PL; Fritzberg AR
J Nucl Med; 1991 Jul; 32(7):1445-51. PubMed ID: 2066805
[TBL] [Abstract][Full Text] [Related]
3. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
Li Y; Tan T; Zheng J; Zhang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
[TBL] [Abstract][Full Text] [Related]
4. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
[TBL] [Abstract][Full Text] [Related]
5. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.
Hnatowich DJ; Qu T; Chang F; Ley AC; Ladner RC; Rusckowski M
J Nucl Med; 1998 Jan; 39(1):56-64. PubMed ID: 9443739
[TBL] [Abstract][Full Text] [Related]
6. [The radiolabeling property of oligonucleotide with 99mTc using NHS-MAG3 as a chelator].
Zhang C; Tan TZ; Kuang AR; Li YC; Zheng JG; Pan WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):169-71. PubMed ID: 15071906
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-labeled monoclonal antibody with preserved immunoreactivity and high in vivo stability.
Arano Y; Yokoyama A; Furukawa T; Horiuchi K; Yahata T; Saji H; Sakahara H; Nakashima T; Koizumi M; Endo K
J Nucl Med; 1987 Jun; 28(6):1027-33. PubMed ID: 3585492
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; Patrício L
Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
[TBL] [Abstract][Full Text] [Related]
9. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
[TBL] [Abstract][Full Text] [Related]
10. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
[TBL] [Abstract][Full Text] [Related]
11. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
12. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
Baidoo KE; Scheffel U; Lever SZ
Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
[TBL] [Abstract][Full Text] [Related]
13. Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography.
Hambÿe AS; Verbeke KA; Vandermeiren RP; Joosens EJ; Verbruggen AM; De Roo MJ
J Nucl Med; 1997 Oct; 38(10):1521-8. PubMed ID: 9379186
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
Zhao M; Zhu X; Ji S; Zhou J; Ozker KS; Fang W; Molthen RC; Hellman RS
J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
[TBL] [Abstract][Full Text] [Related]
15. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with (99m)Tc at room temperature.
Wang Y; Liu X; Hnatowich DJ
Nat Protoc; 2007; 2(4):972-8. PubMed ID: 17446896
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m labeling of DNA oligonucleotides.
Hnatowich DJ; Winnard P; Virzi F; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M
J Nucl Med; 1995 Dec; 36(12):2306-14. PubMed ID: 8523124
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
18. Synthetic copolymer kit for radionuclide blood-pool imaging.
Bogdanov AA; Callahan RJ; Wilkinson RA; Martin C; Cameron JA; Fischman AJ; Brady TJ; Weissleder R
J Nucl Med; 1994 Nov; 35(11):1880-6. PubMed ID: 7965173
[TBL] [Abstract][Full Text] [Related]
19. Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.
Childs RL; Hnatowich DJ
J Nucl Med; 1985 Mar; 26(3):293-9. PubMed ID: 3882905
[TBL] [Abstract][Full Text] [Related]
20. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
